By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Ronda General Mitre, 151

Barcelona      Spain
Phone: 93-291-30-00 Fax: n/a




Company News
European Commission (EC) Approves Almirall’s Skilarence For Moderate-To-Severe Chronic Plaque Psoriasis 6/28/2017 10:15:42 AM
Almirall And LEO Pharma Join Forces To Advance Dermatology Research By Setting A New Standard 5/31/2017 1:21:37 PM
Almirall And Sun Pharma (SUNPHARMA.NS) Announce Regulatory Filing Of Tildrakizumab In Europe 3/24/2017 8:57:53 AM
Almirall Release: Thermi Defends Against Viveve’s Claims Of Patent Infringement 3/17/2017 6:44:20 AM
Almirall And Nuevolution Enter Into A Strategic Collaboration To Develop ROR?t Inhibitors For Treatment Of Dermatology Diseases & Psoriatic Arthritis 12/12/2016 10:40:22 AM
Almirall Release: European Day Of Skin Cancer Prevention 6/13/2016 12:47:59 PM
Almirall Closes The Acquisition Of ThermiGen LLC Entering The Aesthetics Market 2/9/2016 12:06:35 PM
Almirall Exercises Call Option To Acquire 100% Of Thermigen LLC 1/4/2016 11:10:17 AM
Almirall Gains a Dermatory-Focused R&D Structure with $386.3 Million Buy 11/30/2015 6:11:11 AM
Almirall Has Acquired The Rights To Veltin And Altabax From Stiefel, A GlaxoSmithKline (GSK) Company, In Exchange For Its Distribution Rights To Toctino 11/23/2015 10:42:02 AM